Gaudium IVF and Women Health IPO

Gaudium IVF and Women Health Limited IPO Strengths

• Patient-Centric Approach

Gaudium IVF and Women Health Limited prioritizes personalized care, recognizing the uniqueness of each patient. With dedicated counsellors, the company provides emotional support and guidance throughout the parenthood journey. Patients benefit from quality consultations, confidentiality, transparency, and unwavering assistance during their IVF treatment.

• Expert Team

Founded by Dr. Manika Khanna and Dr. Peeyush Khanna, Gaudium IVF brings over two decades of infertility expertise. The Gaudium IVF Foundation, established in 2014, extends healthcare support to underprivileged communities. Expert gynaecologists and embryologists ensure meticulous and compassionate IVF procedures.

• Modern Technology

Gaudium IVF integrates cutting-edge technology to deliver world-class fertility treatments. The use of INTEGRA Ti™ for ICSI procedures, advanced egg quality assessment tools, Samsung Ultrasound Machines, and sterile operating rooms enhances precision and patient safety.

• Highly Technical USG-Guided Services

Gaudium IVF is equipped to manage complex fertility cases using advanced diagnostic techniques, including hysterosalpingography (HSG), transvaginal scans, follicular monitoring, ultrasound-guided biopsies, transrectal ultrasounds, and ovarian cyst aspiration.

• Flexible Payment Options

Gaudium IVF offers tailored payment plans, allowing patients to choose between lump sum payments or convenient instalments based on their financial preferences. These flexible options ensure affordability without compromising treatment quality.

• Asset-Light Business Model

Gaudium IVF operates an efficient, asset-light model with standardized protocols and internal controls. This approach minimizes dependency on individual practitioners, ensuring scalable, high-quality reproductive care across multiple locations.

• Hubs in Major Cities

With central hubs in Mumbai, Bangalore, Delhi NCR, and Patna, Gaudium IVF provides advanced fertility treatments, including IVF, IUI, embryo freezing, and embryo transfer. These hubs serve as centres of excellence, catering to wider geographic areas.

• Spokes Nearby Hubs

Gaudium IVF extends its reach through smaller spoke centres around central hubs, improving accessibility to consultations, initial treatments, and follow-ups. Patients requiring advanced care are referred to nearby hubs, ensuring seamless, high-quality reproductive health services.

More About Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited, incorporated in 2015, is a leading provider of IVF (In Vitro Fertilization) treatment in India. Operating on a hub-and-spoke model, the company has expanded across multiple states, offering comprehensive fertility care.

Founder and Expertise

Founded by Dr. Manika Khanna, a specialist trained in gynecological endoscopic surgery from Kiel, Germany, and Gynaec Endoscopy from Melbourne IVF Gujarat Private Limited, the company is committed to providing advanced fertility treatments.

PAN-India Presence

• 30+ Locations

• 7 IVF Centers (Hubs)

• 28 Spokes (Strategic alliance with Infertility Expert)

• Major Hubs

• Delhi: Janakpuri & Kailash Colony

• Maharashtra: Mumbai (Khar West)

• Punjab: Ludhiana

• Jammu & Kashmir: Srinagar

• Bihar: Patna

• Karnataka: Bangalore

Global Reach

Gaudium IVF serves patients from various countries, including:

• Canada

• United Kingdom

• United States

• Kenya

• South Africa

• Oman

Fertility Treatments Offered

• IVF (In Vitro Fertilization) – Personalized treatment for couples facing infertility.

• IUI (Intrauterine Insemination) – A simple and effective fertility treatment.

• ICSI (Intracytoplasmic Sperm Injection) – A specialized technique for male infertility.

• PCOS/PCOD Treatment – Hormonal care for reproductive health.

• Male Infertility Solutions – Addressing sperm disorders and hormonal imbalances.

• Endometriosis Treatment – Managing infertility caused by endometriosis.

• Ovulation Induction – Stimulating ovulation for better chances of conception.

• Laser-Assisted Embryo Implantation – Enhancing embryo implantation success rates.

• Infertility Surgeries – Specialized surgical interventions for reproductive health.

• Surrogacy Support – Providing medical assistance for surrogacy-related treatments.

Additional Services

• Hospital Facility (Janakpuri, Delhi) – A 15-bed hospital dedicated to women’s and child care.

• Pharmacy Services – An in-house pharmacy at Janakpuri Center catering to patient needs.

Achievements and Recognition

• Asia’s Greatest Brands 2016 (Singapore)

• Symbol of Brand Excellence Award 2018 (London, UK)

• India Best Practices Award – IVF Chain Company of the Year 2019

International Collaboration

In May 2024, Gaudium IVF entered a collaboration agreement with a company in London to provide IVF consultancy and guidance, acting as the company’s exclusive representative in the region.

With a commitment to innovation, patient care, and expanding fertility services globally, Gaudium IVF continues to be a trusted name in reproductive health.

Industry Outlook

IVF Market in India

• Increasing demand due to late marriages, rising infertility rates, and higher maternal age.

• The Indian IVF market, valued at USD 779 million (CY23), is projected to reach USD 1,874 million by CY29, growing at a CAGR of 15.7%.

• India is a key destination for IVF medical tourism due to affordability, expertise, and infrastructure.

Growth Drivers

• Reproductive Tourism: Affordable IVF in India ($3,000–$4,000 vs. $15,000–$20,000 in the U.S.) attracts global patients.

• Technology Advancements: Innovations like assisted hatching, embryo scope, AI-based embryo selection, and PICSI improve success rates.

• Government Support: Loans, subsidies, and medical visas boost accessibility.

• Delayed Parenthood: Career-focused individuals opt for IVF and egg freezing.

• Rising Infertility: Lifestyle factors and age-related fertility decline increase demand.

• Awareness & Acceptance: Educational campaigns reduce stigma, driving IVF adoption.

How Will Gaudium IVF and Women Health Limited Benefit

• Increased Demand for IVF Services: With rising infertility rates, delayed parenthood, and growing awareness, Gaudium IVF is set to benefit from the increasing demand for fertility treatments in India.

• Expansion in Medical Tourism: India’s affordability, expertise, and advanced infrastructure attract international patients. Gaudium IVF’s global reach in countries like Canada, the UK, and the US strengthens its position in the medical tourism market.

• Technological Advancements:Gaudium IVF integrates innovations like AI-based embryo selection, assisted hatching, and laser-assisted embryo implantation, improving success rates and patient trust.

• Strong PAN-India Presence: With 7 IVF centres and 28 strategic spokes, Gaudium IVF has a well-established network, making fertility care accessible across multiple states.

• Government Support and Policies:Favourable policies, including medical visas, subsidies, and financial assistance for fertility clinics, will help Gaudium IVF expand its services.

• International Collaboration: Its 2024 partnership with a London-based company enhances its global footprint, reinforcing its role as a trusted fertility solutions provider.

• Comprehensive Fertility Solutions: Offering IVF, ICSI, IUI, surrogacy, and specialized treatments for PCOS and male infertility, Gaudium IVF meets diverse patient needs, ensuring sustainable growth.

Gaudium IVF and Women Health Limited IPO Overview

Gaudium IVF and Women Health has filed a Draft Red Herring Prospectus (DRHP) with SEBI for its IPO. The book-built issue includes a fresh issue of ₹1.83 crore equity shares and an offer for sale of 183,544 shares. The IPO will be listed on NSE and BSE, with allocations of 35% for retail investors, 50% for QIBs, and 15% for HNIs. Dr. Manika Khanna is selling shares in the OFS. Sarthi Capital Advisors is the lead manager, and Bigshare Services is the registrar.

Gaudium IVF and Women Health Limited Upcoming IPO Details

Category	Details
Issue Type	Book Built Issue IPO
Total Issue Size	Fresh Issue: 1.89 crore shares Offer for Sale (OFS): 0.25 crore shares
IPO Dates	TBA
Price Bands	TBA
Lot Size	TBA
Face Value	₹5 per share
Listing Exchange	BSE, NSE
Shareholding pre-issue	TBA
Shareholding post -issue	TBA

Gaudium IVF and Women Health IPO Important Dates

IPO Activity	Date
IPO Open Date	TBA
IPO Close Date	TBA
Basis of Allotment Date	TBA
Refunds Initiation	TBA
Credit of Shares to Demat	TBA
IPO Listing Date	TBA

Gaudium IVF and Women Health IPO Lots

Application	Lots	Shares	Amount
Retail (Min)	TBA	TBA	TBA
Retail (Max)	TBA	TBA	TBA
S-HNI (Min)	TBA	TBA	TBA
S-HNI (Max)	TBA	TBA	TBA
B-HNI (Min)	TBA	TBA	TBA

Gaudium IVF and Women Health Limited IPO Valuation Overview

KPI	Value
Earnings Per Share (EPS)	2.70
Price/Earnings (P/E) Ratio	TBD
Return on Net Worth (RoNW)	61%
Net Asset Value (NAV)	335.98
Return on Equity	49.90%
Return on Capital Employed (ROCE)	46.27%
EBITDA Margin	48.28%
PAT Margin	30.89%
Debt to Equity Ratio	0.69

Peer Group Comparison

• No Listed peers are available as on the date of Draft Red Herring Prospectus.

Objectives of the IPO Proceeds

The Net Proceeds are intended to be utilised as per the details provided in the table below:

Particulars	Amount (in ₹ lakhs)
Funding capital expenditure towards establishment of New IVF Centers of our Company	9469.92
Funding working capital requirements for establishment of New IVF Centres Investment in the Subsidiary, EKK Global Private Limited for a) Launching of FMCG products; and b) Funding its Working Capital Requirements	395.23 292.25 2207.75
General corporate purposes*	[●]

Note: *To be determined upon finalisation of the Offer Price and updated in the Prospectus prior to filing with the RoC

Gaudium IVF and Women Health Limited Financials (in lakhs)

Particulars	30 Sept 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	7227.02	5729.28	3662.75	1777.08
Revenue	3169.12	5348.46	4423.69	3651.98
Profit After Tax	814.41	1660.12	1352.46	882.82
Reserves and Surplus	1085.18	3227.94	217.86	830.40
Total Borrowings	1947.93	1572.58	978.11	594.82
Total Liabilities	3072.12	2402.32	1389.87	847.66

Key Strategies for Gaudium IVF and Women Health Limited 

• Strategic Expansion and Diversification

Gaudium IVF and Women Health Limited is committed to expanding its services beyond core IVF treatments. The company aims to strengthen its presence across India using a Hub-and-Spoke model, ensuring greater accessibility to high-quality reproductive care in underserved regions. Additionally, it is diversifying into the FMCG sector through its wholly owned subsidiary, EKK Global Private Limited, introducing specialized healthcare products.

• Expansion of IVF Centres Using the Hub-and-Spoke Model

Gaudium IVF is expanding its network using a Hub-and-Spoke model, improving IVF accessibility in underserved regions. This approach ensures consistent service quality, centralizes advanced procedures at hubs, optimizes resources, and strengthens patient referrals within the Gaudium IVF network for better reproductive care.

• Diversification into FMCG Products Through EKK Global Private Limited

Leveraging its extensive network of patients, clinics, and healthcare professionals, Gaudium IVF is entering the FMCG sector. Through its subsidiary, EKK Global Private Limited, the company will introduce specialized mother-and-child wellness products and nutraceuticals aimed at supporting maternal health and managing diabetes.